Selected research
Industry Research
Cell Therapy Development and Manufacturing Services Industry Research Report 2026
Market perspective
The global Cell Therapy Development and Manufacturing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Therapy Development and Manufacturing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Therapy Development and Manufacturing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Therapy Development and Manufacturing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Therapy Development and Manufacturing Services include AGC Biologics, AmplifyBio, Charles River Laboratories, Thermo Fisher Scientific, FUJIFILM Cellular Dynamics, Wuxi AppTec, KBI Biopharma, Lonza and Catalent Biologics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Therapy Development and Manufacturing Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Therapy Development and Manufacturing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Therapy Development and Manufacturing Services Market by Company
AGC Biologics
AmplifyBio
Charles River Laboratories
Thermo Fisher Scientific
FUJIFILM Cellular Dynamics
Wuxi AppTec
KBI Biopharma
Lonza
Catalent Biologics
Oxford BioMedica
GenScript
Cell-Easy
SK pharmteco
RoslinCT
Cell and Gene Therapy Catapult
Cell Therapies
Minaris Regenerative Medicine
MEDINET
Cell Therapy Development and Manufacturing Services Segment by Type
Stem Cell Therapy
Somatic Cell Therapy
Cell Therapy Development and Manufacturing Services Segment by Application
Pharmaceutical Company
Research Institute
Cell Therapy Development and Manufacturing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy Development and Manufacturing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy Development and Manufacturing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy Development and Manufacturing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Therapy Development and Manufacturing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Cell Therapy Development and Manufacturing Services Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Type (2021-2026)
Table 7. Global Cell Therapy Development and Manufacturing Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Type (2027-2032)
Table 9. Global Cell Therapy Development and Manufacturing Services Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Application (2021-2026)
Table 11. Global Cell Therapy Development and Manufacturing Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Application (2027-2032)
Table 13. Global Cell Therapy Development and Manufacturing Services Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Cell Therapy Development and Manufacturing Services Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Cell Therapy Development and Manufacturing Services Market Share by Region (2021-2026)
Table 16. Global Cell Therapy Development and Manufacturing Services Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Cell Therapy Development and Manufacturing Services Market Share by Region (2027-2032)
Table 18. Cell Therapy Development and Manufacturing Services Industry Trends
Table 19. Cell Therapy Development and Manufacturing Services Industry Drivers
Table 20. Cell Therapy Development and Manufacturing Services Industry Opportunities and Challenges
Table 21. Cell Therapy Development and Manufacturing Services Market Restraints
Table 22. Global Top Cell Therapy Development and Manufacturing Services Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Players (2021-2026)
Table 24. Global Cell Therapy Development and Manufacturing Services Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Cell Therapy Development and Manufacturing Services, Headquarters and Area Served
Table 26. Global Cell Therapy Development and Manufacturing Services Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Cell Therapy Development and Manufacturing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Cell Therapy Development and Manufacturing Services Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032) & (US$ Million)
Table 45. AGC Biologics Company Information
Table 46. AGC Biologics Business Overview
Table 47. AGC Biologics Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 48. AGC Biologics Cell Therapy Development and Manufacturing Services Product Portfolio
Table 49. AGC Biologics Recent Developments
Table 50. AmplifyBio Company Information
Table 51. AmplifyBio Business Overview
Table 52. AmplifyBio Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 53. AmplifyBio Cell Therapy Development and Manufacturing Services Product Portfolio
Table 54. AmplifyBio Recent Developments
Table 55. Charles River Laboratories Company Information
Table 56. Charles River Laboratories Business Overview
Table 57. Charles River Laboratories Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 58. Charles River Laboratories Cell Therapy Development and Manufacturing Services Product Portfolio
Table 59. Charles River Laboratories Recent Developments
Table 60. Thermo Fisher Scientific Company Information
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 63. Thermo Fisher Scientific Cell Therapy Development and Manufacturing Services Product Portfolio
Table 64. Thermo Fisher Scientific Recent Developments
Table 65. FUJIFILM Cellular Dynamics Company Information
Table 66. FUJIFILM Cellular Dynamics Business Overview
Table 67. FUJIFILM Cellular Dynamics Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 68. FUJIFILM Cellular Dynamics Cell Therapy Development and Manufacturing Services Product Portfolio
Table 69. FUJIFILM Cellular Dynamics Recent Developments
Table 70. Wuxi AppTec Company Information
Table 71. Wuxi AppTec Business Overview
Table 72. Wuxi AppTec Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 73. Wuxi AppTec Cell Therapy Development and Manufacturing Services Product Portfolio
Table 74. Wuxi AppTec Recent Developments
Table 75. KBI Biopharma Company Information
Table 76. KBI Biopharma Business Overview
Table 77. KBI Biopharma Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 78. KBI Biopharma Cell Therapy Development and Manufacturing Services Product Portfolio
Table 79. KBI Biopharma Recent Developments
Table 80. Lonza Company Information
Table 81. Lonza Business Overview
Table 82. Lonza Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 83. Lonza Cell Therapy Development and Manufacturing Services Product Portfolio
Table 84. Lonza Recent Developments
Table 85. Catalent Biologics Company Information
Table 86. Catalent Biologics Business Overview
Table 87. Catalent Biologics Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 88. Catalent Biologics Cell Therapy Development and Manufacturing Services Product Portfolio
Table 89. Catalent Biologics Recent Developments
Table 90. Oxford BioMedica Company Information
Table 91. Oxford BioMedica Business Overview
Table 92. Oxford BioMedica Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 93. Oxford BioMedica Cell Therapy Development and Manufacturing Services Product Portfolio
Table 94. Oxford BioMedica Recent Developments
Table 95. GenScript Company Information
Table 96. GenScript Business Overview
Table 97. GenScript Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 98. GenScript Cell Therapy Development and Manufacturing Services Product Portfolio
Table 99. GenScript Recent Developments
Table 100. Cell-Easy Company Information
Table 101. Cell-Easy Business Overview
Table 102. Cell-Easy Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 103. Cell-Easy Cell Therapy Development and Manufacturing Services Product Portfolio
Table 104. Cell-Easy Recent Developments
Table 105. SK pharmteco Company Information
Table 106. SK pharmteco Business Overview
Table 107. SK pharmteco Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 108. SK pharmteco Cell Therapy Development and Manufacturing Services Product Portfolio
Table 109. SK pharmteco Recent Developments
Table 110. RoslinCT Company Information
Table 111. RoslinCT Business Overview
Table 112. RoslinCT Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 113. RoslinCT Cell Therapy Development and Manufacturing Services Product Portfolio
Table 114. RoslinCT Recent Developments
Table 115. Cell and Gene Therapy Catapult Company Information
Table 116. Cell and Gene Therapy Catapult Business Overview
Table 117. Cell and Gene Therapy Catapult Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 118. Cell and Gene Therapy Catapult Cell Therapy Development and Manufacturing Services Product Portfolio
Table 119. Cell and Gene Therapy Catapult Recent Developments
Table 120. Cell Therapies Company Information
Table 121. Cell Therapies Business Overview
Table 122. Cell Therapies Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 123. Cell Therapies Cell Therapy Development and Manufacturing Services Product Portfolio
Table 124. Cell Therapies Recent Developments
Table 125. Minaris Regenerative Medicine Company Information
Table 126. Minaris Regenerative Medicine Business Overview
Table 127. Minaris Regenerative Medicine Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 128. Minaris Regenerative Medicine Cell Therapy Development and Manufacturing Services Product Portfolio
Table 129. Minaris Regenerative Medicine Recent Developments
Table 130. MEDINET Company Information
Table 131. MEDINET Business Overview
Table 132. MEDINET Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026) & (US$ Million)
Table 133. MEDINET Cell Therapy Development and Manufacturing Services Product Portfolio
Table 134. MEDINET Recent Developments
Table 135. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Cell Therapy Development and Manufacturing Services Product Image
Figure 5. Global Cell Therapy Development and Manufacturing Services Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Cell Therapy Development and Manufacturing Services Market Share by Type: 2025 VS 2032
Figure 7. Stem Cell Therapy Product
Figure 8. Somatic Cell Therapy Product
Figure 9. Global Cell Therapy Development and Manufacturing Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Cell Therapy Development and Manufacturing Services Market Share by Application: 2025 VS 2032
Figure 11. Pharmaceutical Company Product
Figure 12. Research Institute Product
Figure 13. Global Cell Therapy Development and Manufacturing Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 14. Global Cell Therapy Development and Manufacturing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 15. Global Cell Therapy Development and Manufacturing Services Market Share by Region: 2025 VS 2032
Figure 16. Global Cell Therapy Development and Manufacturing Services Market Share by Players in 2025
Figure 17. Global Cell Therapy Development and Manufacturing Services Manufacturers Established Date
Figure 18. Global Top 5 and 10 Cell Therapy Development and Manufacturing Services Players Market Share by Revenue in 2025
Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. North America Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 21. North America Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
Figure 22. United States Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 23. Canada Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. Mexico Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
Figure 25. Europe Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Europe Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
Figure 27. Germany Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. France Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. U.K. Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Italy Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Spain Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Russia Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Netherlands Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Nordic Countries Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Asia-Pacific Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Asia-Pacific Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
Figure 37. China Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Japan Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. South Korea Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. India Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. India Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
Figure 42. Australia Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. China Taiwan Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. South America Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South America Cell Therapy Development and Manufacturing Services Market Share by Country (2021-2032)
Figure 47. Brazil Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Argentina Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Chile Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Colombia Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Peru Cell Therapy Development and Manufacturing Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. AGC Biologics Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 53. AmplifyBio Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 54. Charles River Laboratories Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 56. FUJIFILM Cellular Dynamics Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 57. Wuxi AppTec Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 58. KBI Biopharma Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 59. Lonza Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 60. Catalent Biologics Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 61. Oxford BioMedica Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 62. GenScript Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 63. Cell-Easy Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 64. SK pharmteco Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 65. RoslinCT Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 66. Cell and Gene Therapy Catapult Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 67. Cell Therapies Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 68. Minaris Regenerative Medicine Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Figure 69. MEDINET Revenue Growth Rate in Cell Therapy Development and Manufacturing Services Business (2021-2026)
Scope & coverage.
Types
- Stem Cell Therapy
- Somatic Cell Therapy
Applications
- Pharmaceutical Company
- Research Institute
Companies covered
- AGC Biologics
- AmplifyBio
- Charles River Laboratories
- Thermo Fisher Scientific
- FUJIFILM Cellular Dynamics
- Wuxi AppTec
- KBI Biopharma
- Lonza
- Catalent Biologics
- Oxford BioMedica
- GenScript
- Cell-Easy
- SK pharmteco
- RoslinCT
- Cell and Gene Therapy Catapult
- Cell Therapies
- Minaris Regenerative Medicine
- MEDINET
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Therapy Development and Manufacturing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Stem Cell Therapy
- 2.2.3 Somatic Cell Therapy
- 2.3 Cell Therapy Development and Manufacturing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Company
- 2.3.3 Research Institute
- 2.4 Assumptions and Limitations
3 Cell Therapy Development and Manufacturing Services Breakdown Data by Type
- 3.1 Global Cell Therapy Development and Manufacturing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Therapy Development and Manufacturing Services Forecasted Market Size by Type (2027-2032)
4 Cell Therapy Development and Manufacturing Services Breakdown Data by Application
- 4.1 Global Cell Therapy Development and Manufacturing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Therapy Development and Manufacturing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Therapy Development and Manufacturing Services Market Perspective (2021-2032)
- 5.2 Global Cell Therapy Development and Manufacturing Services Growth Trends by Region
- 5.2.1 Global Cell Therapy Development and Manufacturing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Therapy Development and Manufacturing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Therapy Development and Manufacturing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Therapy Development and Manufacturing Services Market Dynamics
- 5.3.1 Cell Therapy Development and Manufacturing Services Industry Trends
- 5.3.2 Cell Therapy Development and Manufacturing Services Market Drivers
- 5.3.3 Cell Therapy Development and Manufacturing Services Market Challenges
- 5.3.4 Cell Therapy Development and Manufacturing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Therapy Development and Manufacturing Services Players by Revenue
- 6.1.1 Global Top Cell Therapy Development and Manufacturing Services Players by Revenue (2021-2026)
- 6.1.2 Global Cell Therapy Development and Manufacturing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Therapy Development and Manufacturing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Therapy Development and Manufacturing Services Head Office and Area Served
- 6.4 Global Cell Therapy Development and Manufacturing Services Players, Product Type & Application
- 6.5 Global Cell Therapy Development and Manufacturing Services Manufacturers Established Date
- 6.6 Global Cell Therapy Development and Manufacturing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
- 7.2 North America Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
- 7.4 North America Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
- 8.2 Europe Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
- 8.4 Europe Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
- 10.2 South America Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
- 10.4 South America Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Therapy Development and Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Therapy Development and Manufacturing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AGC Biologics
- 12.1.1 AGC Biologics Company Information
- 12.1.2 AGC Biologics Business Overview
- 12.1.3 AGC Biologics Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.1.4 AGC Biologics Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.1.5 AGC Biologics Recent Developments
- 12.2 AmplifyBio
- 12.2.1 AmplifyBio Company Information
- 12.2.2 AmplifyBio Business Overview
- 12.2.3 AmplifyBio Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.2.4 AmplifyBio Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.2.5 AmplifyBio Recent Developments
- 12.3 Charles River Laboratories
- 12.3.1 Charles River Laboratories Company Information
- 12.3.2 Charles River Laboratories Business Overview
- 12.3.3 Charles River Laboratories Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.3.4 Charles River Laboratories Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.3.5 Charles River Laboratories Recent Developments
- 12.4 Thermo Fisher Scientific
- 12.4.1 Thermo Fisher Scientific Company Information
- 12.4.2 Thermo Fisher Scientific Business Overview
- 12.4.3 Thermo Fisher Scientific Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.4.5 Thermo Fisher Scientific Recent Developments
- 12.5 FUJIFILM Cellular Dynamics
- 12.5.1 FUJIFILM Cellular Dynamics Company Information
- 12.5.2 FUJIFILM Cellular Dynamics Business Overview
- 12.5.3 FUJIFILM Cellular Dynamics Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.5.4 FUJIFILM Cellular Dynamics Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.5.5 FUJIFILM Cellular Dynamics Recent Developments
- 12.6 Wuxi AppTec
- 12.6.1 Wuxi AppTec Company Information
- 12.6.2 Wuxi AppTec Business Overview
- 12.6.3 Wuxi AppTec Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.6.4 Wuxi AppTec Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.6.5 Wuxi AppTec Recent Developments
- 12.7 KBI Biopharma
- 12.7.1 KBI Biopharma Company Information
- 12.7.2 KBI Biopharma Business Overview
- 12.7.3 KBI Biopharma Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.7.4 KBI Biopharma Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.7.5 KBI Biopharma Recent Developments
- 12.8 Lonza
- 12.8.1 Lonza Company Information
- 12.8.2 Lonza Business Overview
- 12.8.3 Lonza Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.8.4 Lonza Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.8.5 Lonza Recent Developments
- 12.9 Catalent Biologics
- 12.9.1 Catalent Biologics Company Information
- 12.9.2 Catalent Biologics Business Overview
- 12.9.3 Catalent Biologics Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.9.4 Catalent Biologics Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.9.5 Catalent Biologics Recent Developments
- 12.10 Oxford BioMedica
- 12.10.1 Oxford BioMedica Company Information
- 12.10.2 Oxford BioMedica Business Overview
- 12.10.3 Oxford BioMedica Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.10.4 Oxford BioMedica Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.10.5 Oxford BioMedica Recent Developments
- 12.11 GenScript
- 12.11.1 GenScript Company Information
- 12.11.2 GenScript Business Overview
- 12.11.3 GenScript Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.11.4 GenScript Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.11.5 GenScript Recent Developments
- 12.12 Cell-Easy
- 12.12.1 Cell-Easy Company Information
- 12.12.2 Cell-Easy Business Overview
- 12.12.3 Cell-Easy Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.12.4 Cell-Easy Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.12.5 Cell-Easy Recent Developments
- 12.13 SK pharmteco
- 12.13.1 SK pharmteco Company Information
- 12.13.2 SK pharmteco Business Overview
- 12.13.3 SK pharmteco Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.13.4 SK pharmteco Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.13.5 SK pharmteco Recent Developments
- 12.14 RoslinCT
- 12.14.1 RoslinCT Company Information
- 12.14.2 RoslinCT Business Overview
- 12.14.3 RoslinCT Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.14.4 RoslinCT Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.14.5 RoslinCT Recent Developments
- 12.15 Cell and Gene Therapy Catapult
- 12.15.1 Cell and Gene Therapy Catapult Company Information
- 12.15.2 Cell and Gene Therapy Catapult Business Overview
- 12.15.3 Cell and Gene Therapy Catapult Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.15.4 Cell and Gene Therapy Catapult Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.15.5 Cell and Gene Therapy Catapult Recent Developments
- 12.16 Cell Therapies
- 12.16.1 Cell Therapies Company Information
- 12.16.2 Cell Therapies Business Overview
- 12.16.3 Cell Therapies Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.16.4 Cell Therapies Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.16.5 Cell Therapies Recent Developments
- 12.17 Minaris Regenerative Medicine
- 12.17.1 Minaris Regenerative Medicine Company Information
- 12.17.2 Minaris Regenerative Medicine Business Overview
- 12.17.3 Minaris Regenerative Medicine Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.17.4 Minaris Regenerative Medicine Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.17.5 Minaris Regenerative Medicine Recent Developments
- 12.18 MEDINET
- 12.18.1 MEDINET Company Information
- 12.18.2 MEDINET Business Overview
- 12.18.3 MEDINET Revenue in Cell Therapy Development and Manufacturing Services Business (2021-2026)
- 12.18.4 MEDINET Cell Therapy Development and Manufacturing Services Product Portfolio
- 12.18.5 MEDINET Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst